Gerdts, Eva

2018 ESC/ESH Guidelines for the management of arterial hypertension

Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 10,286

Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

Phelps, N. H., Singleton, R. K., Zhou, B., Heap, R. A., Mishra, A., Bennett, J. E., Paciorek, C. J., Lhoste, V. P., Carrillo-Larco, R. M., Stevens, G. A., et al. (2024) · The Lancet

Obesity, Physical Activity, DietDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 2,544

2024 ESC Guidelines for the management of elevated blood pressure and hypertension

McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 2,298

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

Rossebø, A. B., Pedersen, T. R., Boman, K., Brudi, P., Chambers, J. B., Egstrup, K., Gerdts, E., Gohlke-Bärwolf, C., Holme, I., Kesäniemi, Y. A., et al. (2008) · New England Journal of Medicine

Lipoproteins and Cardiovascular HealthCardiac Valve Diseases and Treatments

Cited by 1,644

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol

Wachtell, K., Lehto, M., Gerdts, E., Olsen, M. H., Hornestam, B., Dahlöf, B., Ibsen, H., Julius, S., Kjeldsen, S. E., Lindholm, L. H., et al. (2005) · Journal of the American College of Cardiology

Atrial Fibrillation Management and OutcomesBlood Pressure and Hypertension Studies

Cited by 826

Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis

Cioffi, G., Faggiano, P., Vizzardi, E., Tarantini, L., Cramariuc, D., Gerdts, E., & de Simone, G. (2011) · Heart

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 301

Low-Flow Aortic Stenosis in Asymptomatic Patients

Cramariuc, D., Cioffi, G., Rieck, Å. E., Devereux, R. B., Staal, E. M., Ray, S., Wachtell, K., & Gerdts, E. (2009) · JACC: Cardiovascular Imaging

Cardiac Valve Diseases and TreatmentsCardiovascular Function and Risk Factors

Cited by 211

Hypertension in Aortic Stenosis: Implications for Left Ventricular Structure and Cardiovascular Events

Rieck, Å. E., Cramariuc, D., Boman, K., Gohlke-Bärwolf, C., Staal, E. M., Lønnebakken, M. T., Rossebø, A. B., & Gerdts, E. (2012) · Hypertension

Cardiac Valve Diseases and TreatmentsBlood Pressure and Hypertension Studies

Cited by 129

Effect of Obesity on Left Ventricular Mass and Systolic Function in Patients With Asymptomatic Aortic Stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] Substudy)

Lund, B. P., Gohlke-Bärwolf, C., Cramariuc, D., Rossebø, A. B., Rieck, Å. E., & Gerdts, E. (2010) · The American Journal of Cardiology

Cardiovascular Function and Risk FactorsCardiac Valve Diseases and Treatments

Cited by 51